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Abstract  
Context: The present review discusses different studies about the treatment of hemorrhagic shock (HS) with 
hypertonic saline (HTS).  
Evidence acquisition: We have searched the title in the most popular databases containing recent meta-
analysis or randomized clinical trials (RCTs).  
Results: We introduce the hemodynamic effects and mechanisms of action of HTS in HS. Evidence in this field 
shows controversial results. There are some data supporting the potential benefits of HTS infusion in HS. The 
goal of research in this field is to identify the best therapy in HS with the least mortality.  
Conclusion: Our conclusion shows that although HTS can decrease inflammatory response during HS, it can 
attenuate hypercoagulability and cause complications. There are no data supporting less mortality while 
treatment with HTS versus other fluids in HS. 
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CONTEXT  
Is hypertonic saline effective in the treatment of 
hemorrhagic shock? Is it capable of reducing 
mortality in hemorrhagic shock? 
EVIDENCE ACQUISITION 
We searched “hypertonic saline in the treatment of 
hemorrhagic shock” in the most popular databases 
including MEDLINE, the Cochrane Collaboration 
Database, the Center for Research Support, TRIP 
Database, PubMed, Web of Science, and Google 
Scholar. We reviewed the most cited articles 
related to our study. Patient-oriented evidence that 
matters (POEM) was used to support key clinical 
recommendations rather than disease-oriented 
evidence (DOE), for example studies dealing with 
changes in morbidity, mortality, or quality of life 
was the main structure of our research rather than 
studies dealing with mechanistic explanations or 
surrogate end points, such as changes in laboratory 
tests. Studies of patients likely to be representative 
of those in primary care practices, rather than 
subspecialty referral centers were reviewed. We 
tried to ensure that all recommendations were 
based on the highest level of evidence available. In 
particular, we tried to find the answer in an 
authoritative compendium of evidence based 
reviews or at least tried to find a meta-analysis or 
well-designed randomized controlled trial (RCT) to 
support it. Most of the studies used in this review 
are published during the last 20 years. 
RESULTS 
Rapid reduction in blood volume is the main cause 
of hemorrhagic shock (HS). Evidence shows that 
circulatory shock has a high mortality rate. 
Especially when talking about trauma, severe 
hemorrhage after injury carries a mortality rate of 
30-40% and almost 50% of this occurs within 24 
hours of injury (1-4). HS is divided into four stages, 
from mild hemodynamic changes to severe multi-
organ failure and acidemia. Depending on the 
severity of blood loss, the disease manifestations 
will appear (5). Neutrophils play the most 
significant role here, binding to tissue endothelium 
and causing capillary leaks that characterize acute 
respiratory distress syndrome, hepatic or renal 
failures. Inflammatory cytokines are liberated 
during resuscitation, causing membrane injury in 
many cells (6).  
Standard treatment for HS has historically been 
consisted of rapidly infusing isotonic crystalloid. 
Colloids can be used as well, but they have no effect 
on morbidity or mortality (7). Numerous studies 
have suggested that small volume resuscitation 
with hypertonic saline (HTS) can improve 
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hemodynamics and oxygenation in HS (8-10). HTS 
(7.5% saline) has been proposed as a potential 
crystalloid alternative because it has omitted the 
tissue edema effects of isotonic crystalloid 
solutions. HTS has anti-inflammatory and 
immunomodulatory effects and it can decrease 
lung and intestinal injury in animal models of HS 
(11). Many studies have suggested the addition of 
dextran to HTS, aimed at sustaining the 
hemodynamic effect of it. The volume of HTS 
solution given during resuscitation should be 
limited due to the potential risk of hypernatremia 
(12). 
As mentioned before, laboratory studies have 
suggested that small volume resuscitation with 
HTS may be more effective in HS in improving 
central hemodynamics, organ perfusion, and 
oxygen delivery than conventional crystalloid 
solutions (13-15). Furthermore, it is confirmed 
that HTS can limit the inflammatory response, 
prevent lung and liver injury, as well as improve 
intestinal blood flow (16-19). Shi et al. in 2002 
indicated that small volume resuscitation using 
HTS limited lung and gut injury after traumatic HS 
compared to traditional crystalloid resuscitation 
(20). Gut ischemia induced by HS can mediate lung 
injury by neutrophil and cytokines activation, and 
the protective role of HTS appears to be related to 
prohibition of this neutrophil activation (18, 21). 
Oliveira et al. in 2002 published a clinical review 
introducing the main mechanisms of action of HTS: 
“instantaneous mobilization of fluids from 
intracellular to extracellular compartments by the 
osmotic gradient produced by HSS; increased 
myocardial contractility; reduced endothelial and 
tissue edema, improvement in microcirculation; 
improved blood viscosity due to hemodilution; and 
immunomodulation” (22). Pascual et al. in 2002 
showed that HTS diminished neutrophil rolling and 
adherence to endothelium and thus led to less 
vascular leakage in HS. They suggested more usage 
of HTS in the resuscitation of HS in order to 
decrease morbidity and mortality (23). There are 
studies demonstrating the benefits of 
administering hypertonic fluid to trauma patients 
(24-27). In some animal studies like Bahrami et al. 
study of mice, it was found that resuscitation with 
HTS decreased the inflammatory process but not 
the mortality (28). Krausz et al. in 2006 compared 
lactated ringer’s solution with HTS and said that 
HTS was associated with less blood loss and better 
survival in rats (29). 
Nowadays there are large multicentric randomized 
human clinical trials that confirm safety and 
efficiency of HTS resuscitation, but they have failed 
to show a definite survival advantage over 
standard isotonic resuscitation (30-33). A recent 
multicenter trial conducted in the prehospital 
setting showed that initial resuscitation with HTS 
or HTS and dextran, compared with normal saline, 
did not result in superior 28-day survival (34). 
Randomized controlled trials have not found a 
clinically significant difference in outcome when 
HTS was compared with conventional isotonic 
fluids (35).  
Studies of humans have shown that excessive fluid 
therapy can lead to coagulopathy, increased 
acidosis, hypothermia, abdominal compartment 
syndrome, elevated intracranial pressure, and 
immunologic disorders (27, 36-38). Fluid therapy 
is supposed to increase the mortality rate in such 
conditions (39). Saeedi et al. in 2013 compared HTS 
treatment to normal saline and no fluid 
resuscitation in HS in goats. They concluded that 
the group with no fluid resuscitation had 
considerably better results for all features of 
uncontrolled HS, such as pH, hemoglobin level, and 
mean arterial pressure. They found that HTS might 
not be a suitable option in HS (40). Gross et al. 
studied the safety of HTS in HS following 
abdominal trauma in rats in 1988 and reported 
that HTS led to early mortality, severe bleeding, 
and low arterial blood pressure (41). In the study 
of Krausz et al. on rats in 1992, it was determined 
that early (within 15 min) treatment with HTS in 
traumatic HS, could result in increased bleeding, 
hypotension, and early death. On the other hand, 
this danger would not happen if the infusion was 
started 30 min or later (42). 
Discussion 
The potential beneficial effect of small volume 
resuscitation with HTS has been extensively 
studied in HS. The anti-inflammatory effect of HTS 
on neutrophils, oxidative burst, and cytokine 
release has been established in various animal 
models (17-22). These effects have been said to 
reduce the excessive proinflammatory action thus 
reducing the degree of damage to multiple organs. 
Hemodynamic effects have been widely studied, 
but recent data have failed to demonstrate its 
efficacy in reducing mortality. There are few 
studies discussing against treatment with extra 
fluids like HTS at the accident scene in an 
uncontrolled HS setting, because this can lead to 
coagulopathy, increased acidosis, hypothermia, 
abdominal compartment syndrome, elevated 
intracranial pressure, and immunologic disorders. 
The evidence here says HTS therapy might increase 
the mortality rate in such conditions (36-39). 
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Further studies and larger randomized clinical 
trials are required to confirm either effectiveness 
or harmfulness of UHS in the treatment of HS, 
where the administration of fluids is detrimental. 
There is still lack of studies with high level of 
evidence about determining the physiologic 
reasons that support administrating HTS in HS. A 
therapy that simultaneously blocks the vicious 
cycle happening during the treatment phase of HS, 
and improves hemodynamics with greater degree 
as soon as possible, will probably have an 
enormous impact on our ability to manage this 
condition. HTS, in general, seems to fail being the 
best option here. 
CONCLUSIONS 
Our conclusion shows that although HTS can 
decrease inflammatory response during HS, it can 
attenuate hypercoagulability and cause 
complications. There are no data supporting less 
mortality while treatment with HTS versus other 
fluids in HS. 
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